Inozyme Pharma, Inc. - INZY

SEC FilingsOur INZY Tweets

About Gravity Analytica

Recent News

  • 06.05.2025 - Genetic prevalence of ENPP1 Deficiency: 1 in 64,035 pregnancies
  • 05.14.2025 - Petra Duda, M.D., Ph.D.

Recent Filings

  • 06.04.2025 - SC 14D9/A Solicitation, recommendation statements
  • 06.04.2025 - SC TO-T/A Tender offer statement by Third Party
  • 06.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 06.02.2025 - 8-K Current report
  • 06.02.2025 - SC TO-T Tender offer statement by Third Party
  • 06.02.2025 - SC 14D9 Solicitation, recommendation statements
  • 05.30.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.23.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 05.20.2025 - SC14D9C Written communication relating to third party tender offer
  • 05.20.2025 - 4 Statement of changes in beneficial ownership of securities